Alembic Pharmaceuticals receives ANDA approval for Fluoxetine Hydrochloride Tablets
From USFDA
Alembic Pharmaceuticals announced that the Company has received approval from the USFDA for its Abbreviated New Drug Application for Fluoxetine Hydrochloride Tablets, 10 mg and 20 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Prozac Tablets, 10 mg and 20 mg, of Eli Lilly and Company.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Apr 07 2017 | 1:12 PM IST